Kerry O. Cleveland, MD

Professor
University of Tennessee Health Science Center College of Medicine

Disclosure(s): AbbVIe: Honoraria; Merck: Honoraria

Poster(s):

• 920 - Leveling Up: Evaluation of IV vs. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare System
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET